Erik Spaepen

1.3k total citations
56 papers, 981 citations indexed

About

Erik Spaepen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Erik Spaepen has authored 56 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 8 papers in Genetics. Recurrent topics in Erik Spaepen's work include Diabetes Management and Research (27 papers), Diabetes Treatment and Management (17 papers) and Diabetes Management and Education (12 papers). Erik Spaepen is often cited by papers focused on Diabetes Management and Research (27 papers), Diabetes Treatment and Management (17 papers) and Diabetes Management and Education (12 papers). Erik Spaepen collaborates with scholars based in United States, United Kingdom and Belgium. Erik Spaepen's co-authors include Lieven Annemans, Thomas Gilbert, G. Nuki, M. Gaskin, Mireille Bonnemaire, Carine Michiels, Gregor Theilmeier, Ingrid Vreys, D Collen and Jos Vermylen and has published in prestigious journals such as Blood, PLoS ONE and Diabetes.

In The Last Decade

Erik Spaepen

49 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Spaepen United States 13 369 315 193 139 119 56 981
Mislav Radić Croatia 17 129 0.3× 192 0.6× 204 1.1× 41 0.3× 92 0.8× 102 1.1k
Özkan Güngör Türkiye 16 301 0.8× 165 0.5× 52 0.3× 231 1.7× 183 1.5× 107 991
Ammon Handisurya Austria 21 141 0.4× 267 0.8× 188 1.0× 304 2.2× 129 1.1× 33 1.3k
Christine Peloquin United States 14 178 0.5× 234 0.7× 376 1.9× 29 0.2× 75 0.6× 34 1.1k
Katsunobu Yoshioka Japan 18 184 0.5× 163 0.5× 138 0.7× 236 1.7× 170 1.4× 70 1.0k
Jutta Gellermann Germany 22 770 2.1× 233 0.7× 106 0.5× 104 0.7× 402 3.4× 40 1.6k
Irene Capelli Italy 21 466 1.3× 223 0.7× 115 0.6× 168 1.2× 89 0.7× 84 1.1k
Assumpta Serra Spain 14 376 1.0× 342 1.1× 63 0.3× 245 1.8× 117 1.0× 26 1.0k
Jui Wang Taiwan 19 111 0.3× 121 0.4× 114 0.6× 96 0.7× 77 0.6× 59 957
Joana E. Kist‐van Holthe Netherlands 22 336 0.9× 154 0.5× 47 0.2× 57 0.4× 100 0.8× 44 1.1k

Countries citing papers authored by Erik Spaepen

Since Specialization
Citations

This map shows the geographic impact of Erik Spaepen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Spaepen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Spaepen more than expected).

Fields of papers citing papers by Erik Spaepen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Spaepen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Spaepen. The network helps show where Erik Spaepen may publish in the future.

Co-authorship network of co-authors of Erik Spaepen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Spaepen. A scholar is included among the top collaborators of Erik Spaepen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Spaepen. Erik Spaepen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Marc, et al.. (2025). Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study. Advances in Therapy. 42(6). 2821–2832. 2 indexed citations
2.
Newson, Rachel S., Esther Artime, Julie K. Bower, et al.. (2025). Understanding Suboptimal Insulin Use in Type 1 and Type 2 Diabetes: A Cross-Sectional Survey of People with Diabetes. Patient Preference and Adherence. Volume 19. 1625–1638.
3.
Bellido, Virginia, Natalia Duque, Rachel S. Newson, et al.. (2024). The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective. Patient Preference and Adherence. Volume 18. 151–164.
4.
Ampudia‐Blasco, Francisco Javier, Natalia Duque, Esther Artime, et al.. (2023). Which people with diabetes are treated with a disposable, half‐unit insulin pen? A real‐world, retrospective, database study in Spain. Endocrinology Diabetes & Metabolism. 6(6). e451–e451. 1 indexed citations
5.
Orozco‐Beltrán, Domingo, Adriana López‐Pineda, José A. Quesada, et al.. (2023). Barriers and solutions for the management of severe hypoglycaemia in people with diabetes in Spain: A Delphi survey. Primary care diabetes. 18(1). 65–73. 1 indexed citations
6.
Heidenreich, Sebastian, et al.. (2022). POSB372 Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Diabetes Patients in the UK and US. Value in Health. 25(1). S233–S233. 1 indexed citations
7.
8.
Bilhim, Tiago, Nuno Vasco Costa, Daniel Torres, Luís Campos Pinheiro, & Erik Spaepen. (2022). Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period. CardioVascular and Interventional Radiology. 45(9). 1324–1336. 48 indexed citations
9.
Iwahori, Toshiyuki, Frank J. Snoek, Yukiko Nagai, et al.. (2022). Conversations and Reactions Around Severe Hypoglycemia (CRASH): Japan Results From a Global Survey of People with T1DM or Insulin-Treated T2DM and Caregivers. Diabetes Therapy. 13(3). 517–533. 4 indexed citations
10.
Heidenreich, Sebastian, et al.. (2022). Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes. Patient. 16(2). 127–138. 8 indexed citations
11.
12.
Chen, Jieling, Magaly Perez‐Nieves, Erik Spaepen, et al.. (2020). An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany. Postgraduate Medicine. 132(8). 727–736.
13.
Jabbar, Abdul, Wan Mohd Izani Wan Mohamed, Erik Spaepen, et al.. (2019). Fasting experience of patients with Type 2 diabetes mellitus on insulin therapy during Ramadan: VISION Ramadan substudy. Diabetes Research and Clinical Practice. 151. 285–289. 7 indexed citations
14.
Jabbar, Abdul, Ahmed Hassoun, Rachid Malek, et al.. (2019). Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region. Diabetes Research and Clinical Practice. 149. 18–26. 21 indexed citations
15.
Kerner, Arthur, Eitan Abergel, Majdi Halabi, et al.. (2013). Should Proximal LAD be treated differently? Insights from a large DES stent registry. Cardiovascular revascularization medicine. 14(6). 325–332. 8 indexed citations
16.
Spaepen, Erik, Mark Lamotte, E. Walter, et al.. (2011). PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH. Value in Health. 14(3). A60–A60. 2 indexed citations
17.
Annemans, Lieven, Simon Wessely, Erik Spaepen, et al.. (2008). Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis & Rheumatism. 58(3). 895–902. 104 indexed citations
18.
Annemans, Lieven, et al.. (2008). Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium. Journal of Medical Economics. 11(1). 135–150. 33 indexed citations
19.
Annemans, Lieven, Erik Spaepen, M. Gaskin, et al.. (2007). Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Annals of the Rheumatic Diseases. 67(7). 960–966. 373 indexed citations
20.
Ethgen, Olivier, Erik Spaepen, K Moeremans, & Lieven Annemans. (2005). Economic impact of hospital malnutrition. Ghent University Academic Bibliography (Ghent University). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mislav Radić Breakdown of academic impact, for papers by Özkan Güngör Breakdown of academic impact, for papers by Ammon Handisurya Breakdown of academic impact, for papers by Christine Peloquin Breakdown of academic impact, for papers by Katsunobu Yoshioka Breakdown of academic impact, for papers by Jutta Gellermann Breakdown of academic impact, for papers by Irene Capelli Breakdown of academic impact, for papers by Assumpta Serra Breakdown of academic impact, for papers by Jui Wang Breakdown of academic impact, for papers by Joana E. Kist‐van Holthe
Rankless by CCL
2026